Agency Forms Undergoing Paperwork Reduction Act Review, 4038-4039 [E9-1227]
Download as PDF
<![CDATA[
4038
Federal Register / Vol. 74, No. 13 / Thursday, January 22, 2009 / Notices
officers promptly respond to this report
by meeting the incoming conveyance
(when possible), collecting information
and evaluating the patient(s), and
determining whether an ill person can
safely be admitted into the U.S. If
Quarantine Station staff are unable to
meet the conveyance, the crew or
medical staff of the conveyance are
trained to complete the required
documentation and forward it (using a
secure system) to the Quarantine Station
for review and follow-up.
To perform these tasks in a
streamlined manner and ensure that all
relevant information is collected in the
most efficient and timely manner
possible, Quarantine Stations use a
number of forms—the Airline Screening
and Illness Response Form, the Ship
Illness/Death Reporting Form, and the
Land/Border Crossing Form—to collect
data on passengers with suspected
illness and other travelers/crew who
may have been exposed to an illness.
These forms are also used to respond to
a report of a death aboard a conveyance.
The purpose of all of the forms is the
same: to collect information that helps
quarantine officials detect and respond
to potential public health
communicable disease threats. All forms
collect the following categories of
information: demographics and mode of
transportation, clinical and medical
history, and any other relevant facts
(e.g., travel history, traveling
companions, etc.). As part of this
documentation, quarantine public
health officers look for specific signs
and symptoms common to the nine
quarantinable diseases (Pandemic
influenza; SARS; Cholera; Plague;
Diphtheria; Infectious Tuberculosis;
Smallpox; Yellow fever; and Viral
Hemorrhagic Fevers), as well as most
communicable diseases in general.
These signs and symptoms include
fever, difficulty breathing, shortness of
breath, cough, diarrhea, jaundice, or
signs of a neurological infection. The
forms also collect data specific to the
traveler’s conveyance.
These data are used by Quarantine
Stations to make decisions about a
passenger’s suspected illness as well as
its communicability. This in turn
enables Quarantine Station staff to assist
conveyances in the public health
management of passengers and crew.
The estimated total burden on the
public, included in the chart below, can
vary a great deal depending on the
severity of the illness being reported,
the number of contacts, the number of
follow-up inquiries required, and who is
recording the information (e.g.,
Quarantine Station staff versus the
conveyance medical authority). In all
cases, Quarantine Stations have
implemented practices and procedures
that balance the health and safety of the
American public against the public’s
desire for minimal interference with
their travel and trade. Whenever
possible, Quarantine Station staff obtain
information from other documentation
(e.g., manifest order, other airline
documents) to reduce the amount of the
public burden.
There is no cost to respondents other
than their time to complete the survey.
The total estimated annualized burden
for this data collection is 172 hours.
ESTIMATE OF ANNUALIZED BURDEN
Number of
respondents
Respondents
Airline Illness or Death Investigation Form .................................................................................
International Maritime Illness or Death Report ............................................................................
International Maritime Illness or Death Investigation Form .........................................................
Land Border Illness or Death Investigation Form .......................................................................
Dated: January 12, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–1225 Filed 1–21–09; 8:45 am]
BILLING CODE 4163–18–P
mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Centers for Disease Control and
Prevention
State Medicaid Tobacco Coverage
Survey—Reinstatement—National
Center for Chronic Disease Prevention
and Control (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
[30Day–09–0691]
Background and Brief Description
Agency Forms Undergoing Paperwork
Reduction Act Review
Tobacco use remains the leading
preventable cause of death in the United
States despite the availability of
evidence-based treatments for tobacco
dependence, which include counseling
and FDA-approved pharmacotherapies.
To increase both the use of treatment by
smokers attempting to quit and the
number of smokers who quit
successfully, the Guide to Community
Preventive Services recommends
reducing the out-of-pocket cost of
rmajette on PRODPC74 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an e-
VerDate Nov<24>2008
14:47 Jan 21, 2009
Jkt 217001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
1320
200
200
60
Number of
responses per
respondent
1
1
1
1
Average
burden per
response
(in hours)
6/60
3/60
7/60
6/60
effective tobacco-dependence
treatments, and the Public Health
Service (PHS) Clinical Practice
Guideline supports expanded insurance
coverage for tobacco-dependence
treatment.
Medicaid recipients have
approximately 50% greater smoking
prevalence than the overall U.S. adult
population, and they are
disproportionately affected by tobaccorelated disease and disability.
Information about the amount and type
of coverage for tobacco-dependence
treatment offered by Medicaid has been
collected during 1998, 2000, 2001, 2002,
2003, 2005, 2006, and 2007. Information
collection for the three most recent
years (2005–2007) was conducted by the
Centers for Disease Control and
Prevention (OMB No. 0920–0691,
expiration date 8/31/2008). Respondents
were Medicaid directors or their
designees in all 50 states and the
District of Columbia.
CDC requests OMB approval to
reinstate information collection for an
E:\FR\FM\22JAN1.SGM
22JAN1
4039
Federal Register / Vol. 74, No. 13 / Thursday, January 22, 2009 / Notices
additional three-year period. Responses
will be submitted electronically using a
web-based survey instrument. Minor
changes to the instrument are proposed
to address compliance with
recommendations made in the updated
PHS clinical practice guideline issued
in May of 2008, such as coverage for
combination therapies, smokeless
tobacco use, and states’ familiarity with
and use of the 2000 PHS guideline. The
minor changes are not expected to affect
the overall burden estimate. To
minimize burden, each respondent will
only be asked to record changes that
occurred since the time of the previous
submission. As in previous years, each
respondent will also attach a copy of the
state’s Medicaid coverage plan to their
completed survey, in order to assist the
research team with the interpretation of
responses.
The information to be collected will
allow CDC to continue monitoring
compliance with the most recent PHS
recommendations and the progress of
State Medicaid Programs toward the
2010 National Health Objectives and
Healthy People 2010 goals.
There are no costs to respondents
except the time to complete the survey.
The total estimated burden hours are 26.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
State Medicaid Programs ............................................................................................................
51
1
30/60
Dated: January 13, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–1227 Filed 1–21–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
The National Institute for Occupational
Safety and Health (NIOSH) of the
Centers for Disease Control and
Prevention (CDC) Announces an
Evaluation of Downdraft Vented Nail
Salon Tables (VNTs)
Authority: 29 U.S.C. Sections 651 et seq.
AGENCY: National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice.
The Division of Applied
Research and Technology (DART),
NIOSH, is conducting an evaluation of
downdraft vented salon nail tables
(VNTs). This notice invites developers,
manufacturers, and vendors of VNTs to
submit new, unused, downdraft VNTs
for evaluation of operational
characteristics and effectiveness in
reducing levels of a source point tracer
gas at standard distances from the vent.
A 6-month supply of manufacturer
recommended filters is to be submitted
to NIOSH at the address below, together
with the VNT.
Evaluation parameters for the VNTs
will include, but are not limited to:
rmajette on PRODPC74 with NOTICES
SUMMARY:
VerDate Nov<24>2008
14:47 Jan 21, 2009
Jkt 217001
Airflow and capture characteristics,
noise level, ergonomic features, and
filter life. Manufacturers, vendors, and
developers who wish to submit VNTs
with filters for evaluation are invited to
respond to this announcement. A report
on each VNT submitted for evaluation,
including feedback on the evaluation
parameters and staff recommendations,
will be sent to the submitter. Results of
the evaluation will potentially be used
to develop educational materials for nail
technicians and may also be
disseminated through reports,
publications, or presentations. NIOSH
does not intend to identify
manufacturers in its publications but
testing information referencing
particular manufacturers would be
releasable if requested under the
Freedom of Information Act (FOIA).
DATES: Written letter of interest must be
received within 90 calendar days of
publication in the Federal Register. The
deadline for receipt of VNT and filter
submissions is June 30, 2009.
Evaluations will begin subject to the
dates VNT and filter submissions are
received. The VNTs will be retained for
up to 10 months while being evaluated,
after which they will be returned.
ADDRESSES: Manufacturers, vendors,
and developers who wish to submit
VNTs with filters for evaluation are
invited to respond to this
announcement by sending a written
letter of interest to NIOSH/DART,
Robert A. Taft Laboratories, 4676
Columbia Parkway, Mailstop C–23,
Cincinnati, Ohio 45226, Attention:
Susan Reutman, e-mail address:
SReutman@cdc.gov.
SUPPLEMENTARY INFORMATION: Responses
shall include: A description of the VNT
including the manufacturer, schedule of
availability of the VNT and filters for
evaluation, and a statement of the terms
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
under which the VNT will be made
available for evaluation. Shipping and
handling costs (including insurance) to
ship the VNTs to NIOSH and for NIOSH
to return the VNTs to the submitter will
be the responsibility of the submitter.
NIOSH reserves the right to decide
which VNT submissions will be
evaluated based on compliance with the
specifications described above. NIOSH
also reserves the right not to proceed in
this manner.
Note: As a government entity, we cannot
endorse any specific product directly,
indirectly, or by implication. NIOSH will not
be responsible for any costs related to usage,
wear and tear or accidental damage to the
VNT during transport or while the VNT is at
NIOSH.
Contact Person for Technical
Information: Susan Reutman, Ph.D.,
telephone (513) 533–8286, or e-mail
SReutman@cdc.gov.
Dated: January 2, 2009.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–1193 Filed 1–21–09; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–D–0264]
Compliance Policy Guide Sec.
540.370—Fish and Fishery Products—
Decomposition; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 74, Number 13 (Thursday, January 22, 2009)]
[Notices]
[Pages 4038-4039]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-1227]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-09-0691]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
State Medicaid Tobacco Coverage Survey--Reinstatement--National
Center for Chronic Disease Prevention and Control (NCCDPHP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Tobacco use remains the leading preventable cause of death in the
United States despite the availability of evidence-based treatments for
tobacco dependence, which include counseling and FDA-approved
pharmacotherapies. To increase both the use of treatment by smokers
attempting to quit and the number of smokers who quit successfully, the
Guide to Community Preventive Services recommends reducing the out-of-
pocket cost of effective tobacco-dependence treatments, and the Public
Health Service (PHS) Clinical Practice Guideline supports expanded
insurance coverage for tobacco-dependence treatment.
Medicaid recipients have approximately 50% greater smoking
prevalence than the overall U.S. adult population, and they are
disproportionately affected by tobacco-related disease and disability.
Information about the amount and type of coverage for tobacco-
dependence treatment offered by Medicaid has been collected during
1998, 2000, 2001, 2002, 2003, 2005, 2006, and 2007. Information
collection for the three most recent years (2005-2007) was conducted by
the Centers for Disease Control and Prevention (OMB No. 0920-0691,
expiration date 8/31/2008). Respondents were Medicaid directors or
their designees in all 50 states and the District of Columbia.
CDC requests OMB approval to reinstate information collection for
an
[[Page 4039]]
additional three-year period. Responses will be submitted
electronically using a web-based survey instrument. Minor changes to
the instrument are proposed to address compliance with recommendations
made in the updated PHS clinical practice guideline issued in May of
2008, such as coverage for combination therapies, smokeless tobacco
use, and states' familiarity with and use of the 2000 PHS guideline.
The minor changes are not expected to affect the overall burden
estimate. To minimize burden, each respondent will only be asked to
record changes that occurred since the time of the previous submission.
As in previous years, each respondent will also attach a copy of the
state's Medicaid coverage plan to their completed survey, in order to
assist the research team with the interpretation of responses.
The information to be collected will allow CDC to continue
monitoring compliance with the most recent PHS recommendations and the
progress of State Medicaid Programs toward the 2010 National Health
Objectives and Healthy People 2010 goals.
There are no costs to respondents except the time to complete the
survey. The total estimated burden hours are 26.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State Medicaid Programs...................................... 51 1 30/60
----------------------------------------------------------------------------------------------------------------
Dated: January 13, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-1227 Filed 1-21-09; 8:45 am]
BILLING CODE 4163-18-P
